WASHINGTON—Demand for long-lasting factory goods fell sharply in June, a sign overseas turmoil is weighing on U.S. manufacturers.
The iPhone maker provided another sober reminder of how its days of hyper growth are long gone. Apple (AAPL, Tech30) posted its second-straight quarter of shrinking sales, led by another drop in smartphone shipments.
WASHINGTON—A measure of homes under contract for sale rose slightly in June, as ongoing job growth and low interest rates continued to support the U.S.
Teva Pharmaceutical Industries Ltd. TEVA 1.49 % on Wednesday won regulatory approval from the Federal Trade Commission for its acquisition of Allergan PLC's generics business, conditioned upon Teva's divestiture of 75 drugs to rivals.
(Adds details from conference call, new throughout). By Tom Polansek. CHICAGO, July 27 Oreo maker Mondelez International Inc is fighting back against aggressive rivals in North America after its share of the biscuit market there declined in the second ...